Aperture Therapeutics
PrivateLast Round
Grant
Jun 15, 2026
Total Funding Raised
$1.09M
Company Overview
Aperture Therapeutics is a biotechnology company that develops oligonucleotide therapies for neurodegenerative diseases by leveraging human genetic resilience.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aperture Therapeutics Comparables
Compare Aperture Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Riboway Therapeutics | 78% | |
| NuCyRNA Therapeutics | 73% | |
| Trace Neuroscience | 68% |
Aperture Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 15, 2026 | ||||
| Accelerator | Apr 7, 2025 | ||||
| Grant | Jul 2, 2024 |
Aperture Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LongGame Ventures | Seed |
| age1 | Seed |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| Ferocity Capital | Seed |
| Conscience VC | Seed |
| Ono Venture Investment, Inc. | Accelerator |
| Mission BioCapital | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2025
Monthly visitors grew 417% MoM to 3.8K.
- Apr 7, 2025
$500K round led by Mission BioCapital.
Aperture Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aperture Therapeutics's valuation, stock price, and market status.
Is Aperture Therapeutics a public or private company?
Aperture Therapeutics is a private company.
What is the current stock price of Aperture Therapeutics?
Aperture Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Aperture Therapeutics worth (valuation)?
Valuation information for Aperture Therapeutics is not publicly available.
Can I buy Aperture Therapeutics stock?
Aperture Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aperture Therapeutics's last funding round?
Aperture Therapeutics's most recent funding round was Grant on June 15, 2026.
Who are the main investors in Aperture Therapeutics?
Key investors in Aperture Therapeutics include Mission BioCapital.
Will Aperture Therapeutics IPO soon?
No public IPO plans have been announced for Aperture Therapeutics.
How can I track Aperture Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aperture Therapeutics's secondary market activity and sign up for updates.